New guidelines recommend nerve blocks for migraine ER treatment
People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids to quell their…
Migraine and risk of all-cause mortality and specific cause mortality: a systematic review and meta-analysis | The Journal of Headache and Pain
Main finding This meta-analysis did not reveal a significant association between AM and all-cause, cardiovascular, or suicide mortality,…
The prevalence of headache disorders in children and adolescents in Nepal: a schools-based cross-sectional study | The Journal of Headache and Pain
This schools-based study in Nepal was the Global Campaign’s first in SEAR. We found that the vast majority…
Dear Abby: Husband’s depression increases with each rejection letter, following restructuring layoff
DEAR ABBY: My husband was let go from his job due to restructuring. He’s understandably upset, and I…
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…